✦ LIBER ✦

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

✍ Scribed by Fabian Schnitzler; Herma Fidder; Marc Ferrante; Vera Ballet; Maja Noman; Gert Van Assche; Bernard Spitz; Ilse Hoffman; Kristel Van Steen; Séverine Vermeire; Paul Rutgeerts

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 272 KB
Volume: 17
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21583

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Presentation and outcome of histoplasmos

Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series

✍ Jennifer L. Dotson; Wallace Crandall; Hayat Mousa; Jonathan R. Honegger; Lee Den 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 1 views

Background: Antitumor necrosis factor alpha (aTNF) therapies are commonly used in the treatment of pediatric inflammatory bowel disease (IBD). However, inhibition of the TNF-alpha pathway predisposes to serious infections, including histoplasmosis, which is the most common invasive fungal infection

Differences in the incidence of flares o

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents

✍ Braun, J. ;Baraliakos, X. ;Listing, J. ;Davis, J. ;van der Heijde, D. ;Haibel, H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## Objective Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are clinically and pathologically linked. Anti–tumor necrosis factor (anti‐TNF) agents are efficacious in treating AS, but not all are equally effective in treating IBD (Crohn's disease [CD] and ulcerative co